1. Home
  2. BDSX vs JMM Comparison

BDSX vs JMM Comparison

Compare BDSX & JMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • JMM
  • Stock Information
  • Founded
  • BDSX 2005
  • JMM 1988
  • Country
  • BDSX United States
  • JMM United States
  • Employees
  • BDSX N/A
  • JMM N/A
  • Industry
  • BDSX Precision Instruments
  • JMM Trusts Except Educational Religious and Charitable
  • Sector
  • BDSX Health Care
  • JMM Finance
  • Exchange
  • BDSX Nasdaq
  • JMM Nasdaq
  • Market Cap
  • BDSX 53.2M
  • JMM 60.4M
  • IPO Year
  • BDSX 2020
  • JMM N/A
  • Fundamental
  • Price
  • BDSX $0.41
  • JMM $6.29
  • Analyst Decision
  • BDSX Strong Buy
  • JMM
  • Analyst Count
  • BDSX 5
  • JMM 0
  • Target Price
  • BDSX $1.75
  • JMM N/A
  • AVG Volume (30 Days)
  • BDSX 1.4M
  • JMM 16.1K
  • Earning Date
  • BDSX 08-07-2025
  • JMM 01-01-0001
  • Dividend Yield
  • BDSX N/A
  • JMM 5.44%
  • EPS Growth
  • BDSX N/A
  • JMM N/A
  • EPS
  • BDSX N/A
  • JMM N/A
  • Revenue
  • BDSX $76,556,000.00
  • JMM N/A
  • Revenue This Year
  • BDSX $17.29
  • JMM N/A
  • Revenue Next Year
  • BDSX $29.33
  • JMM N/A
  • P/E Ratio
  • BDSX N/A
  • JMM N/A
  • Revenue Growth
  • BDSX 25.70
  • JMM N/A
  • 52 Week Low
  • BDSX $0.17
  • JMM $5.29
  • 52 Week High
  • BDSX $2.04
  • JMM $6.10
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 53.27
  • JMM 46.14
  • Support Level
  • BDSX $0.37
  • JMM $6.21
  • Resistance Level
  • BDSX $0.43
  • JMM $6.39
  • Average True Range (ATR)
  • BDSX 0.04
  • JMM 0.09
  • MACD
  • BDSX -0.00
  • JMM -0.02
  • Stochastic Oscillator
  • BDSX 48.25
  • JMM 32.00

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About JMM Nuveen Multi-Market Income Fund (MA)

Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities including, but not limited to residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.

Share on Social Networks: